Stock listing
NASDAQ:MNPR Monopar Therapeutics Inc. Stock
Home listing (NASDAQ) of Monopar Therapeutics Inc.
Follow Monopar Therapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MNPR
$70.32 USD -1.59 (-2.2%)
Close on Oct 30, 2026
- Day range
- $69.35 – $72.76 USDOct 30, 2026
- Volume
- 197,763 sharesOct 30, 2026
- Market cap
- $472.0M USDAt the close on Oct 30, 2026 · price × 6.71M shares outstanding
- 52-week range
- $50.07 – $124.82 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $17.77M USDMedian day 152,500 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MNPR · Home | $70.32 USD | -1.59 (-2.2%) | 197,763 | $71.36 | $72.76 | $69.35 | $71.91 | Close on Oct 30, 2026 |
| Frankfurt:1IY0 | €61.40 EUR | -1.90 (-3.0%) | — | €63.40 | €63.60 | €61.40 | €63.30 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:MNPR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $70.32 | -1.59 | -2.2% | $71.36 | $72.76 | $69.35 | 197,763 | |
| $71.91 | -1.48 | -2.0% | $73.90 | $75.29 | $70.65 | 163,098 | |
| $73.39 | +1.55 | +2.2% | $72.04 | $73.39 | $69.94 | 187,362 | |
| $71.84 | +1.30 | +1.8% | $72.00 | $73.99 | $70.20 | 135,923 | |
| $70.54 | -0.11 | -0.2% | $71.01 | $71.85 | $69.34 | 79,014 | |
| $70.65 | -1.93 | -2.7% | $71.84 | $71.84 | $69.48 | 95,500 | |
| $72.58 | +0.23 | +0.3% | $71.83 | $73.13 | $71.22 | 117,400 | |
| $72.35 | -1.88 | -2.5% | $73.47 | $75.08 | $70.95 | 87,300 | |
| $74.23 | +2.76 | +3.9% | $72.20 | $74.90 | $71.95 | 86,600 | |
| $71.47 | +2.20 | +3.2% | $70.10 | $72.32 | $69.71 | 67,600 | |
| $69.27 | -2.53 | -3.5% | $71.01 | $71.01 | $68.81 | 161,600 | |
| $71.80 | -1.30 | -1.8% | $73.20 | $73.28 | $70.05 | 140,900 | |
| $73.10 | +1.02 | +1.4% | $70.74 | $74.01 | $70.51 | 129,600 | |
| $72.08 | -4.97 | -6.5% | $76.16 | $76.92 | $71.66 | 249,900 | |
| $77.05 | -1.91 | -2.4% | $79.30 | $79.59 | $75.05 | 128,500 | |
| $78.96 | -5.02 | -6.0% | $83.47 | $84.04 | $78.80 | 135,800 | |
| $83.98 | +0.20 | +0.2% | $82.48 | $85.49 | $81.27 | 185,500 | |
| $83.78 | +4.21 | +5.3% | $78.28 | $85.03 | $77.98 | 107,000 | |
| $79.57 | +1.28 | +1.6% | $78.04 | $82.66 | $75.33 | 302,200 | |
| $78.29 | +0.32 | +0.4% | $78.72 | $79.59 | $76.24 | 128,300 | |
| $77.97 | 0.00 | 0.0% | $78.36 | $80.00 | $77.03 | 107,600 | |
| $77.97 | -1.70 | -2.1% | $79.64 | $80.33 | $77.59 | 130,800 | |
| $79.67 | -0.33 | -0.4% | $80.00 | $82.35 | $79.33 | 226,300 | |
| $80.00 | -3.72 | -4.4% | $82.77 | $83.04 | $79.38 | 162,400 | |
| $83.72 | -1.515 | -1.8% | $85.24 | $86.69 | $82.92 | 268,200 | |
| $85.24 | -3.605 | -4.1% | $89.58 | $90.00 | $85.06 | 105,800 | |
| $88.84 | -0.54 | -0.6% | $88.03 | $90.05 | $86.54 | 252,900 | |
| $89.38 | -7.25 | -7.5% | $96.78 | $96.78 | $87.59 | 89,300 | |
| $96.63 | +0.91 | +1.0% | $96.60 | $97.37 | $94.01 | 136,000 | |
| $95.72 | -0.75 | -0.8% | $97.92 | $98.19 | $94.95 | 89,200 | |
| $96.47 | -6.23 | -6.1% | $102.44 | $102.45 | $95.96 | 382,800 | |
| $102.70 | +1.25 | +1.2% | $103.33 | $104.09 | $98.90 | 206,600 | |
| $101.45 | -2.88 | -2.8% | $105.48 | $105.49 | $100.13 | 89,600 | |
| $104.33 | -3.99 | -3.7% | $106.93 | $106.93 | $101.89 | 91,800 | |
| $108.32 | -1.94 | -1.8% | $111.99 | $111.99 | $107.02 | 106,600 | |
| $110.26 | +0.30 | +0.3% | $113.84 | $113.84 | $109.77 | 90,000 | |
| $109.96 | -2.42 | -2.2% | $110.55 | $112.56 | $108.84 | 89,500 | |
| $112.38 | -2.00 | -1.7% | $112.31 | $116.61 | $112.19 | 110,300 | |
| $114.38 | -3.18 | -2.7% | $115.61 | $117.61 | $113.27 | 103,900 | |
| $117.56 | -0.99 | -0.8% | $117.85 | $119.00 | $116.21 | 81,400 | |
| $118.55 | +2.27 | +2.0% | $117.44 | $121.02 | $115.07 | 208,600 | |
| $116.28 | -1.29 | -1.1% | $119.04 | $121.00 | $114.28 | 203,300 | |
| $117.57 | +5.64 | +5.0% | $110.21 | $118.00 | $110.21 | 95,200 | |
| $111.93 | +0.04 | 0.0% | $110.70 | $112.97 | $106.67 | 141,900 | |
| $111.89 | -2.05 | -1.8% | $112.85 | $113.99 | $109.14 | 221,500 | |
| $113.94 | +0.22 | +0.2% | $113.80 | $117.50 | $112.45 | 142,800 | |
| $113.72 | +2.90 | +2.6% | $111.26 | $114.75 | $108.22 | 123,800 | |
| $110.82 | -0.54 | -0.5% | $113.11 | $114.79 | $108.84 | 133,188 | |
| $111.36 | +3.64 | +3.4% | $106.99 | $113.47 | $104.48 | 239,187 | |
| $107.72 | -3.16 | -2.8% | $111.98 | $113.46 | $105.42 | 176,400 | |
| $110.88 | -12.96 | -10.5% | $122.01 | $122.60 | $110.84 | 208,100 | |
| $123.84 | +4.79 | +4.0% | $118.50 | $124.27 | $114.81 | 400,300 | |
| $119.05 | +2.56 | +2.2% | $115.00 | $120.00 | $113.79 | 143,400 | |
| $116.49 | +3.45 | +3.1% | $113.35 | $117.00 | $111.60 | 171,100 | |
| $113.04 | +2.63 | +2.4% | $109.04 | $113.56 | $107.78 | 165,700 | |
| $110.41 | -4.49 | -3.9% | $110.17 | $113.24 | $108.23 | 162,400 | |
| $114.90 | +0.44 | +0.4% | $115.19 | $117.46 | $110.51 | 354,200 | |
| $114.46 | -1.89 | -1.6% | $116.97 | $117.36 | $113.25 | 210,800 | |
| $116.35 | -2.86 | -2.4% | $118.45 | $120.14 | $114.84 | 280,300 | |
| $119.21 | -1.00 | -0.8% | $121.85 | $124.42 | $118.04 | 223,300 | |
| $120.21 | +0.98 | +0.8% | $119.95 | $124.82 | $119.31 | 285,800 | |
| $119.23 | +0.77 | +0.7% | $119.00 | $120.23 | $114.50 | 182,700 | |
| $118.46 | +6.82 | +6.1% | $112.61 | $120.28 | $112.06 | 215,100 | |
| $111.64 | +3.29 | +3.0% | $108.35 | $114.50 | $104.75 | 489,200 | |
| $108.35 | -6.31 | -5.5% | $114.80 | $116.69 | $107.11 | 431,300 | |
| $114.66 | +7.235 | +6.7% | $106.59 | $116.52 | $106.59 | 327,100 |
- Ticker
- NASDAQ:MNPR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data
Latest deck · May 2026
EASL Congress 2026
Conference · 16 slides
Latest news
Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026
Aug 19, 2026
Closed $123.84 (+4.0%) on Aug 19, 2026
Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug 13, 2026
Closed $110.41 (-3.9%) on Aug 13, 2026
Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
Jul 22, 2026
Closed $112.48 (-1.0%) on Jul 22, 2026
Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team
Jul 20, 2026
Closed $105.90 (-4.7%) on Jul 20, 2026
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
Jun 26, 2026
Closed $94.56 (+7.8%) on Jun 29, 2026
Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026
Jun 1, 2026
Closed $64.40 (-1.0%) on Jun 1, 2026
Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
May 14, 2026
Closed $60.99 (-0.7%) on May 14, 2026
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026
Apr 19, 2026
Closed $54.70 (-2.7%) on Apr 20, 2026
Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
Mar 27, 2026
Closed $54.10 (-0.8%) on Mar 27, 2026
Decks
EASL Congress 2026
Conference · 16 slides · May 2026
Investor Presentation (May 2026)
Investor deck · 37 slides · May 2026
American Academy of Neurology (AAN) 2026
Conference · 10 slides · April 2026
AASLD 2025
Conference · 26 slides · November 2025
Monopar Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 135 in all · newest Nov 2, 2026 · oldest 2019
- Decks
- 7 decks · latest May 2026
Where Monopar Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MNPR · Home listing · This page | NASDAQ | United States | USD |
| Tradegate:1IY0 | Tradegate | Germany | EUR |
| LS Exchange:A40JML | LS Exchange | Germany | EUR |
| gettex:1IY0 | gettex | Germany | EUR |
| Lang & Schwarz:A40JML | Lang & Schwarz | Germany | EUR |
| BOATS:MNPR | BOATS | United States | USD |
| Frankfurt:1IY0 | Frankfurt | Germany | EUR |
| Munich:1IY0 | Munich | Germany | EUR |
| Stuttgart:1IY0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Monopar Therapeutics Inc.